Pen Needles Industry Size

The report "Pen Needles Market by Type (Standard Pen Needles, Safety Pen Neddles),Length (8mm, 5mm), Setting( Home Care Settings), Application (Glucagon like Peptide -1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase)- Global Forecast to 2031" is projected to reach USD 3.37 billion by 2031 from USD 2.16 billion in 2026, at a CAGR of 9.3% during the forecast period.

Browse 200 market data Tables and 80 Figures spread through 300 Pages and in-depth TOC on "Pen Needles Market by Type (Standard Pen Needles, Safety Pen Neddles),Length (8mm, 5mm), Setting( Home Care Settings), Application (Glucagon like Peptide -1 Therapy), Mode of Purchase (Over the Counter Purchase, Online Purchase)- Global Forecast to 2031 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pen-needles-market-75948613.html

Pen needles are made more accessible through various government support programs. Many governments around the world, particularly in North America and Europe, have recognized the importance of proper diabetes management and are investing in programs that make insulin delivery systems, including pen needles, available to patients. These programs typically provide subsidies or insurance coverage for diabetes-related supplies; hence, they reduce the burden of diabetes. For example, in the US, Medicare and Medicaid cover pen needles as part of the cost of insulin delivery devices. This provides patients, especially those from low-income households, with the means to manage their diabetes. Similarly, in Europe, countries have been increasing cost coverage for pens and needles used in diabetes management to enhance patient adherence to diabetes care and minimize the long-term complications associated with poor diabetes management. In addition, government programs support awareness and educational initiatives so that patients become more aware of diabetes and the need for proper insulin injection at regular intervals. These programs, combined with financial aid for insulin delivery systems, propel the adoption of pen needles, improve patient outcomes, and enhance overall quality in diabetes care. This is imperative in dealing with the ever-rising global epidemic of diabetes.

The standard pen needles segment accounted for the largest share of the global pen needles market.

Due to their wide acceptance and affordability, the standard pen needles segment retains the largest market share in the global pen needles market. These needles can be easily bought from pharmacies, hospitals, and online platforms available in most places, making them accessible to most consumers. Moreover, compatibility with any insulin pen as well as most injectable drug delivery devices makes these needles very convenient for people with diabetes to manage the chronic disease. Lower price as compared to advanced options attracts cost-conscious patients and healthcare systems, particularly in developing regions. Online platforms make them even more accessible through competitive pricing, discounts, and convenience, as a patient can order these pen needles while staying at home. They are most available, hence leading in the global market.

The online purchase segment is expected to grow at the highest CAGR in the global pen needles market during the forecast period.

The global online purchase segment is expected to have the highest CAGR, driven by demand for e-commerce websites. Through an online portal, these various pen needles are available from multiple manufacturers, and hence, consumers can easily compare them with regard to specifications, prices, and features. Such transparency of information empowers the customer and encourages him to make a well-informed decision, opting for the right kind of pen needles. In addition, e-commerce websites provide extra benefits such as doorstep delivery, competitive prices, and sometimes discounts or offers. This accessibility and convenience, along with the increased trend of online shopping, make e-commerce a very attractive option for buying pen needles, especially in areas where traditional pharmacies are scarce or charge more.

The Asia Pacific region is expected to exhibit the highest growth rate during the forecast period.

The Asia Pacific region is expected to register the highest CAGR in the global market for pen needles, driven by the rising number of diabetes cases in countries such as China and India. Rapid population growth and increasing urbanization, coupled with poor dietary habits and less physical activity, have contributed to higher diabetes rates. Consequently, insulin delivery solutions such as pen needles have seen growing demand. Beyond the large diabetic population, improved infrastructure and healthcare, along with rising awareness of diabetes management, are driving pen needle use in these regions. For instance, a convenient, easy-to-use product that does not strain patients' budgets is driving rising pen needle sales by making diabetes treatment possible.

Key Market Players:

Key players in this market are adopting several organic and inorganic growth strategies (such as product launches, agreements, collaborations, acquisitions, and expansions). Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), MDT (Italy), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), ARKRAY, Inc. (Japan), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Medical Devices Inc. (Canada), Montmed, Inc. (Canada), Trividia Health, Inc. (US), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).

Don’t miss out on business opportunities in Pen Needles Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com